These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34648702)

  • 1. A renaissance in the treatment of diabetic kidney disease, hypertension in chronic kidney disease, and beyond.
    Yahr J; Calle J; Taliercio JJ
    J Osteopath Med; 2021 Oct; 122(1):55-63. PubMed ID: 34648702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of hypertension and its complications: theoretical basis and guidelines for treatment.
    Flack JM; Peters R; Shafi T; Alrefai H; Nasser SA; Crook E
    J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S92-8. PubMed ID: 12819310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing chronic kidney disease in diabetes patients with the latest chemical therapies.
    Hu J; Du Y
    Expert Rev Clin Pharmacol; 2019 Jan; 12(1):53-60. PubMed ID: 30509118
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of Higher Quality of Care on Initiation of Long-term Dialysis in Patients With CKD and Diabetes.
    Wu HY; Fukuma S; Shimizu S; Norton EC; Tu YK; Hung KY; Chen MR; Chien KL; Fukuhara S
    Am J Kidney Dis; 2017 Nov; 70(5):666-674. PubMed ID: 28764919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiovascular protection of diabetic patient with chronic renal disease and particular case of end-stage renal disease in elderly patients].
    Zaoui P; Hannedouche T; Combe C
    Nephrol Ther; 2017 Jun; 13(6S):6S16-6S24. PubMed ID: 29463395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
    Thomas MC; Atkins RC
    Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Educational paper: Progression in chronic kidney disease and prevention strategies.
    Schaefer B; Wühl E
    Eur J Pediatr; 2012 Nov; 171(11):1579-88. PubMed ID: 22968936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiopathogenesis of kidney disease in minority populations and an updated special focus on treatment in diabetes and hypertension.
    Umeukeje EM; Washington JT; Nicholas SB
    J Natl Med Assoc; 2022 Jun; 114(3S2):S3-S9. PubMed ID: 35589418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic kidney disease, diabetes mellitus and cardiovascular disease: risks and commonalities.
    Suckling R; Gallagher H
    J Ren Care; 2012 Feb; 38 Suppl 1():4-11. PubMed ID: 22348359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Status Quo and Research Progress in Diagnosis and Treatment of Patients With Diabetes Mellitus and Chronic Kidney Disease].
    Dai PY; Yuan QJ; Peng ZZ; Xie YY; Tao LJ; Huang L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):987-996. PubMed ID: 38173112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Managing diabetic kidney disease].
    Alder H; Ambühl PM
    Ther Umsch; 2020 Sep; 77(7):333-338. PubMed ID: 32996426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease and its relationship with chronic kidney disease.
    Liu M; Li XC; Lu L; Cao Y; Sun RR; Chen S; Zhang PY
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2918-26. PubMed ID: 25339487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?
    Sarafidis PA; Ruilope LM
    Kidney Int; 2014 Mar; 85(3):536-46. PubMed ID: 24048382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing care for Canadians with diabetic nephropathy in 2015.
    Lloyd A; Komenda P
    Can J Diabetes; 2015 Jun; 39(3):221-8. PubMed ID: 25805325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological strategies for kidney function preservation: are there differences by ethnicity?
    Lakkis J; Weir MR
    Adv Ren Replace Ther; 2004 Jan; 11(1):24-40. PubMed ID: 14730536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the management of chronic kidney disease.
    Rivera JA; O'Hare AM; Harper GM
    Am Fam Physician; 2012 Oct; 86(8):749-54. PubMed ID: 23062158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies.
    Minutolo R; Gabbai FB; Provenzano M; Chiodini P; Borrelli S; Garofalo C; Sasso FC; Santoro D; Bellizzi V; Conte G; De Nicola L
    Nephrol Dial Transplant; 2018 Nov; 33(11):1942-1949. PubMed ID: 29509925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations and controversies in managing chronic kidney disease: An update.
    Prasad-Reddy L; Isaacs D; Kantorovich A
    Am J Health Syst Pharm; 2017 Jun; 74(11):795-810. PubMed ID: 28546302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.